MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of Life in African American and White Parkinson’s Disease Patients

D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman (Chicago, USA)

Meeting: 2022 International Congress

Abstract Number: 1457

Keywords: Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To determine the quality of life of African American (AA) and White patients with Parkinson’s disease (PD) at the Rush University Medical Center (RUMC) Movement Disorders Clinic

Background: The literature describing PD and impact on quality of life (QoL) or other non-motor features is less robust in AA compared to White patients. This study focused on motor, non-motor and other QoL measures in AA PD patients compared to Whites.

Method: Patients with PD in a tertiary clinic were approached to participate in a study examining PD in AA and White patients. After consent, demographics were collected and a battery of tests were performed, including the MDS-UPDRS Part III, NIH Toolbox measures, Patient Health Expectation Questionnaire, Quality of Life in Neurological Disorders Scale (NeuroQoL), Parkinson’s Disease Questionnaire (PDQ39), Schwab and England, Epworth Sleepiness Scale, and UPSIT smell test.

Results: 24 AA PD and 25 White PD patients participated. 47% of the participants were women, average age was 66.9 (+8.18) years old, mean MDS-UPDRS Part III score was 22.2 (+8.87), 74.5% were Hoehn and Yahr stage II (range II to IV); with no differences between groups. AA PD participants had lower scores on the NeuroQoL satisfaction with participation (p=0.03) and NeuroQoL mobility scales (p=0.01), with no difference in NeuroQoL sleep or fatigue scales. Total PDQ39 scores were significantly higher (worse) in the AA participants (p=0.01) with higher scores on the PDQ39 mobility (p=0.01), ADL (p=0.01), cognition (p=0.02), and body discomfort (p=0.04) sections. There were no differences in patient health expectations, Schwab England disability scores, Epworth or UPSIT scores.

Conclusion: Despite similar MDS-UPDRS motor, non-motor scores and overall disability; AA with PD had lower satisfaction with participation in daily activities, mobility, cognition and body discomfort compared to White PD patients. Further work is needed to determine specific interventions that can address these disparities.

To cite this abstract in AMA style:

D. Hall, S. Anderson, G. Stebbins, L. Barnes, M. Bailey, L. Shulman. Quality of Life in African American and White Parkinson’s Disease Patients [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/quality-of-life-in-african-american-and-white-parkinsons-disease-patients/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-in-african-american-and-white-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley